Clinical characteristics of patients with autoimmune hepatitis seropositive for anticentromere antibody

Hepatology Research

Volumn 40, Issue 8, 2010, Pages 786-792

  Himoto, Takashi ^a   Murota, Masayuki ^a   Yoneyama, Hirohito ^a   Deguchi, Akihiro ^a   Kurokochi, Kazutaka ^a   Senda, Shoichi ^a   Haba, Reiji ^a   Watanabe, Seishiro ^b   Nishioka, Mikio ^a   Masaki, Tsutomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Anticentromere antibody; Autoimmune hepatitis; Concurrent autoimmune diseases; Diversity of nuclear antigens; Immunoglobulin G subclass

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LABORATORY TEST; LIVER FAILURE; MALE; PRIORITY JOURNAL; RELAPSE; SCORING SYSTEM;

EID: 77955254834     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2010.00684.x     Document Type: Article

References (30)

1. Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006, 354:54-66.
2. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994, 107:200-7.
3. Moroi Y, Peebles C, Flitzler MJ, Steigerwald J, Tan EM. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 1980, 77:1627-31.
4. Berstein RM, Callender ME, Neuberger JM, Hughes GRV, Williams R. Anticentromere antibody in primary biliary cirrhosis. Am Rheum Dis 1982, 41:612-14.
5. Makinen D, Fritzler M, Davis P, Sherlock S. Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 1983, 26:914-17.
6. Imai H, Kiyosawa K, Yamaguchi K. The clinical significance of anticentromere antibodies (ACA) in sera of patients with autoimmune liver disease. Acta Hepatol Jpn 1987, 28:1164-71.
7. Nakamura M, Kondo H, Mori T. Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatology 2007, 45:118-27.
8. Yang WH, Yu JH, Nakajima A, Neuberg D, Lindor K, Bloch DB. Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin Gastroenterol Hepatol 2004, 2:1116-22.
9. Parveen S, Morshed SA, Arima K. Antibodies to Ro/La, Cenp-B, and snRNPs antigens in autoimmune hepatitis of North America versus Asia: patterns of immunofluorescence, ELISA reactivities, and HLA association. Dig Dis Sci 1998, 43:1322-31.
10. Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E. Immunomorphological characterization of antinuclear antibodies in chronic liver disease. J Clin Pathol 1985, 38:801-5.
11. Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J Clin Immunol 2006, 26:438-46.
12. Himoto T, Nakai S, Kinekawa F. Clinical characteristics of patients with hepatitis C virus-related chronic liver disease seropositive for anticentromere antibody. Dig Dis Sci 2009, 54:360-8.
13. Terada S, Morshed SA, Nishioka M. Anti-nuclear antibodies in autoimmune hepatitis. Autoimmune Hepatiis 1994, 177-84. Nishioka M, Toda G, Zeniya M. In, eds., Amsterdam, Lonson, New York, Tokyo, Elsevier
14. Yabe H, Noma K, Tada N, Mochizuki S, Nagano M. A case of CREST syndrome with rapidly progressive liver damage. Intern Med 1992, 31:69-73.
15. Alvarez F, Berg PA, Bianchi FB. International Autoimmune Hepatitis Group Report: review of criteria for a diagnosis of autoimmune hepatitis. J Hepatol 1999, 31:929-38.
16. Earnshaw WC, Sullivan KF, Machlin PS. Molecular cloning of cDNA for CENP-B, the major human centromere autoantigen. J Cell Biol 1987, 104:817-29.
17. Knodell RG, Ishak KG, Black WC. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-5.
18. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol 1978, 69:103-20.
19. Miyake Y, Iwasaki Y, Kobayashi H. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis 2010, 42:210-15.
20. Iwai M, Masayasu J, Ishii M, Mori T, Harada Y. Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis. Hepatol Res 2008, 38:784-9.
21. Manns MP, Vogel A. Autoimmune hepatitis, from mechanism to therapy. Hepatology 2006, 43:S132-44.
22. Ishikawa M, Okada J, Shibuya A, Kondo H. CRST syndrome (Calcinosis cutis, Raynaud's phenomenon, sclerodactyly, and telangiectasia) associated with autoimmune hepatitis. Intern Med 1995, 34:6-9.
23. Aoki A, Kirino Y, Ishigatsubo Y, Senuma A, Nagaoka S. Liver involvement in primary Sjögren's syndrome. Jpn Clin Immunol 2004, 27:397-401.
24. Katano K, Kawano M, Koni I, Sugai S, Muro Y. Clinical and laboratory features of anticentromere antibody positive primary Sjögren's syndrome. J Rheumatol 2001, 28:2238-44.
25. Outschoorn I, Rowley MJ, Cool AD, Mackay IR. Subclasses of immunoglobulins and autoantibodies in autoimmune diseases. Clin Immunol Immunopathol 1993, 66:59-66.
26. Czaja AJ, Muratori L, Carpenter HA, Bianchi FB. Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis. Liver Int 2004, 24:322-9.
27. Seki T, Kiyosawa K, Inoko H, Ota M. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients. Hepatology 1990, 12:1300-4.
28. Tojo J, Ohira H, Suzuki T. Clinicolaboratory characteristics of patients with primary billiary cirrhosis associated with CREST syndrome. Hepatol Res 2002, 22:187-95.
29. Zuber M, Gotzen R, Filier I. Clinical correlation of anticentromere antibodies. Clin Rheumatol 1994, 13:427-32.
30. Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y, Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000, 19:123-6.